32 related articles for article (PubMed ID: 7540951)
1. E2f3 is critical for normal cellular proliferation.
Humbert PO; Verona R; Trimarchi JM; Rogers C; Dandapani S; Lees JA
Genes Dev; 2000 Mar; 14(6):690-703. PubMed ID: 10733529
[TBL] [Abstract][Full Text] [Related]
2. E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.
Chen D; Yu Z; Zhu Z; Lopez CD
J Biol Chem; 2008 May; 283(22):15381-9. PubMed ID: 18348985
[TBL] [Abstract][Full Text] [Related]
3. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug.
Wang J; Yin H; Panandikar A; Gandhi V; Sen S
Int J Oncol; 2015 Aug; 47(2):782-90. PubMed ID: 26058363
[TBL] [Abstract][Full Text] [Related]
4. YAP regulates S-phase entry in endothelial cells.
Shen Z; Stanger BZ
PLoS One; 2015; 10(1):e0117522. PubMed ID: 25635998
[TBL] [Abstract][Full Text] [Related]
5. S-phase-coupled apoptosis in tumor suppression.
Cho YJ; Liang P
Cell Mol Life Sci; 2011 Jun; 68(11):1883-96. PubMed ID: 21437646
[TBL] [Abstract][Full Text] [Related]
6. Integration of the pRB and p53 cell cycle control pathways.
Stewart CL; Soria AM; Hamel PA
J Neurooncol; 2001 Feb; 51(3):183-204. PubMed ID: 11407592
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis: A Current Molecular Analysis.
Tang DG; Porter AT
Pathol Oncol Res; 1996; 2(3):117-131. PubMed ID: 11173595
[TBL] [Abstract][Full Text] [Related]
8. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.
Nip J; Strom DK; Fee BE; Zambetti G; Cleveland JL; Hiebert SW
Mol Cell Biol; 1997 Mar; 17(3):1049-56. PubMed ID: 9032231
[TBL] [Abstract][Full Text] [Related]
9. The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis.
Yonish-Rouach E
Experientia; 1996 Oct; 52(10-11):1001-7. PubMed ID: 8917731
[TBL] [Abstract][Full Text] [Related]
10. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
Wu CL; Classon M; Dyson N; Harlow E
Mol Cell Biol; 1996 Jul; 16(7):3698-706. PubMed ID: 8668186
[TBL] [Abstract][Full Text] [Related]
11. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL; Hall DJ
Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
[TBL] [Abstract][Full Text] [Related]
12. Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1.
Smulson ME; Simbulan-Rosenthal CM; Boulares AH; Yakovlev A; Stoica B; Iyer S; Luo R; Haddad B; Wang ZQ; Pang T; Jung M; Dritschilo A; Rosenthal DS
Adv Enzyme Regul; 2000; 40():183-215. PubMed ID: 10828352
[No Abstract] [Full Text] [Related]
13. Role of E2F1 in apoptosis: a case study in feedback loops.
Knezevic D; Brash DE
Cell Cycle; 2004 Jun; 3(6):729-32. PubMed ID: 15107604
[TBL] [Abstract][Full Text] [Related]
14. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ
Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F-1 transcription factor.
Logan TJ; Jordan KL; Evans DL; Hall DJ
J Cell Biochem; 1997 Apr; 65(1):83-94. PubMed ID: 9138083
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
